Herbalife Pyarmid Scheme

Here's a look at the top tickers trending on StockTwits.com Ariad Pharmaceuticals: Buyout rumors persist On Friday, analysts at BMO Capital upgraded Ariad Pharmaceuticals (NASDAQ: ARIA) from Market Perform to Outperform with a price target raised to $14 from a previous $8. The analysts noted...